{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:38:51Z","timestamp":1790282331210,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Center for Research and Development","award":["STRATEGMED1\/233226\/11\/NCBR\/2015"],"award-info":[{"award-number":["STRATEGMED1\/233226\/11\/NCBR\/2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-1075-y","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T04:31:28Z","timestamp":1543897888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics"],"prefix":"10.1186","volume":"20","author":[{"given":"Kamil","family":"Kus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jasztal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Stojak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Chlopicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"issue":"1","key":"1075_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2014an update. Cancer Epidemiol Biomark Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1075_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpba.2013.08.041","volume":"87","author":"EG Armitage","year":"2014","unstructured":"Armitage EG, Barbas C. Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed Anal. 2014;87:1\u201311.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"1075_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/metabo3030552","volume":"3","author":"RD Beger","year":"2013","unstructured":"Beger RD. A review of applications of metabolomics in cancer. Metabolites. 2013;3(3):552\u201374.","journal-title":"Metabolites"},{"issue":"7","key":"1075_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1075_CR5","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41598-017-01924-9","volume":"7","author":"NI Hadi","year":"2017","unstructured":"Hadi NI, Jamal Q, Iqbal A, Shaikh F, Somroo S, Musharraf SG. Serum metabolomic profiles for breast cancer diagnosis, grading and staging by gas chromatography-mass spectrometry. Sci Rep. 2017;7(1):1715.","journal-title":"Sci Rep"},{"key":"1075_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/gm336","volume":"4","author":"C Denkert","year":"2012","unstructured":"Denkert C, Bucher E, Hilvo M, Salek R, Ore\u0161i\u010d M, Griffin J, Brockm\u00f6ller S, Klauschen F, Loibl S, Darupal DK, Budczies J, Iljin K, Nekjudova V, et al. Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery. Genome Med. 2012;4:37.","journal-title":"Genome Med"},{"issue":"8","key":"1075_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1668","volume":"5","author":"V Bronte","year":"2005","unstructured":"Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005;5(8):641\u201354.","journal-title":"Nat Rev Immunol."},{"issue":"12","key":"1075_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nm.4222","volume":"22","author":"T Eisenberg","year":"2016","unstructured":"Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A, Tong M, Ruckenstuhl C, Dammbrueck C, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22(12):1428\u201338.","journal-title":"Nat Med"},{"key":"1075_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1600-065X.2010.00915.x","volume":"236","author":"U Grohmann","year":"2010","unstructured":"Grohmann U, Bronte V. Control of immune response by amino acid metabolism. Immunol Rev. 2010;236:243\u201364.","journal-title":"Immunol Rev"},{"issue":"3","key":"1075_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, Kogadeeva M, Picotti P, Meissner F, Mann M, Zamboni N, Sallusto F, Lanzavecchia A. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167(3):829\u201342.","journal-title":"Cell"},{"issue":"21","key":"1075_CR11","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1007\/s00018-016-2278-y","volume":"73","author":"C Shipp","year":"2016","unstructured":"Shipp C, Speigl L, Janssen N, Martens A, Pawelec G. A clinical and biological perspective of human myeloid-derived suppressor cells in cancer. Cell Mol Life Sci. 2016;73(21):4043\u201361.","journal-title":"Cell Mol Life Sci"},{"key":"1075_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fimmu.2017.00086","volume":"8","author":"LA Elliott","year":"2017","unstructured":"Elliott LA, Doherty GA, Sheahan K, Ryan EJ. Human tumor-infiltrating myeloid cells: phenotypic and functional diversity. Front Immunol. 2017;8:86.","journal-title":"Front Immunol"},{"issue":"4","key":"1075_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/PPO.0b013e3181eb3358","volume":"16","author":"S Nagaraj","year":"2010","unstructured":"Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer J. 2010;16(4):348\u201353.","journal-title":"Cancer J"},{"issue":"7","key":"1075_CR14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.intimp.2011.01.003","volume":"11","author":"TF Greten","year":"2011","unstructured":"Greten TF, Manns MP, Korangy F. Myeloid derived suppressor cells in human diseases. Int Immunopharmacol. 2011;11(7):802\u20136.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1075_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1075_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"1","key":"1075_CR17","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogene. 2016;5(1):e189.","journal-title":"Oncogene"},{"issue":"7503","key":"1075_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature13474","volume":"510","author":"JCM Holthuis","year":"2014","unstructured":"Holthuis JCM, Menon AK. Lipid landscapes and pipelines in membrane homeostasis. Nature. 2014;510(7503):48\u201357.","journal-title":"Nature"},{"issue":"9","key":"1075_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00595-002-2563-2","volume":"33","author":"MF Polat","year":"2003","unstructured":"Polat MF, Taysi S, Polat S, B\u00f6y\u00fck A, Bakan E. Elevated serum arginase activity levels in patients with breast cancer. Surg Today. 2003;33(9):655\u201361.","journal-title":"Surg Today"},{"issue":"1","key":"1075_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","volume":"6","author":"M Sugimoto","year":"2010","unstructured":"Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6(1):78\u201395.","journal-title":"Metabolomics"},{"issue":"3\u20134","key":"1075_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000430844","volume":"82","author":"UL Gunther","year":"2015","unstructured":"Gunther UL. Metabolomics biomarkers for breast cancer. Pathobiology. 2015;82(3\u20134):153\u201365.","journal-title":"Pathobiology"},{"issue":"1","key":"1075_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/1471-2164-13-334","volume":"13","author":"J Budczies","year":"2012","unstructured":"Budczies J, Denkert C, M\u00fcller BM, Brockm\u00f6ller SF, Klauschen F, Gy\u00f6rffy B, Dietel M, Richter-Ehrenstein C, Marten U, Salek RM, Griffin JL, Hilvo M, Ore\u0161i\u010d M, et al. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study. BMC Genomics. 2012;13(1):334.","journal-title":"BMC Genomics"},{"issue":"21","key":"1075_CR23","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","volume":"70","author":"VM Asiago","year":"2010","unstructured":"Asiago VM, Alvarado LZ, Shanaiah N, Gowda GAN, Owusu-Sarfo K, Ballas RA, Raftery D. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res. 2010;70(21):8309\u201318.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"1075_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clinbiochem.2011.10.011","volume":"45","author":"W Lv","year":"2012","unstructured":"Lv W, Yang T. Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem. 2012;45(1\u20132):127\u201333.","journal-title":"Clin Biochem"},{"issue":"2","key":"1075_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/pr200685r","volume":"11","author":"SF Brockm\u00f6ller","year":"2012","unstructured":"Brockm\u00f6ller SF, Bucher E, M\u00fcller BM, Budczies J, Hilvo M, Griffin JL, Ore\u0161i\u010d M, Kallioniemi O, Iljin K, Loibl S, Darb-Esfahani S, Sinn BV, Klauschen F, et al. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer\u2014link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res. 2012;11(2):850\u201360.","journal-title":"J Proteome Res"},{"issue":"9","key":"1075_CR26","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-10-3894","volume":"71","author":"M Hilvo","year":"2011","unstructured":"Hilvo M, Denkert C, Lehtinen L, M\u00fcller B, Brockm\u00f6ller S, Sepp\u00e4nen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, et al. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res. 2011;71(9):3236\u201345.","journal-title":"Cancer Res"},{"issue":"4","key":"1075_CR27","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.3390\/ijms14048047","volume":"14","author":"Y Qiu","year":"2013","unstructured":"Qiu Y, Zhou B, Su M, Baxter S, Zheng X, Zhao X, Yen Y, Jia W. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients. Int J Mol Sci. 2013;14(4):8047\u201361.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1075_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2407-8-228","volume":"8","author":"K Tao","year":"2008","unstructured":"Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer. 2008;8(1):228.","journal-title":"BMC Cancer"},{"issue":"9","key":"1075_CR29","first-page":"1926","volume":"7","author":"M Smeda","year":"2017","unstructured":"Smeda M, Przyborowski K, Proniewski B, Zakrzewska A, Kaczor D, Stojak M, Buczek E, Nieckarz Z, Zoladz JA, Wietrzyk J, Chlopicki S. Breast cancer pulmonary metastasis is increased in mice undertaking spontaneous physical training in the running wheel: a call for revising beneficial effects of exercise on cancer progression. Am J Cancer Res. 2017;7(9):1926\u201336.","journal-title":"Am J Cancer Res"},{"issue":"25","key":"1075_CR30","doi-asserted-by":"publisher","first-page":"17810","DOI":"10.18632\/oncotarget.24891","volume":"9","author":"M Smeda","year":"2018","unstructured":"Smeda M, Kieronska A, Proniewski B, Jasztal A, Selmi A, Wandzel K, Zakrzewska A, Wojcik T, Przyborowski K, Derszniak K, Stojak M, Kaczor D, Buczek E, et al. Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour. Oncotarget. 2018;9(25):17810\u201324.","journal-title":"Oncotarget"},{"issue":"1","key":"1075_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13058-018-1013-z","volume":"20","author":"M Smeda","year":"2018","unstructured":"Smeda M, Kieronska A, Adamski MG, Proniewski B, Sternak M, Mohaissen T, Przyborowski K, Derszniak K, Kaczor D, Stojak M, Buczek E, Jasztal A, Wietrzyk J, et al. NO deficiency and endothelial\u2013mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice. Breast Cancer Res. 2018;20(1):86.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1075_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12885-018-4445-z","volume":"18","author":"E Buczek","year":"2018","unstructured":"Buczek E, Denslow A, Mateuszuk L, Proniewski B, Wojcik T, Sitek B, Fedorowicz A, Jasztal A, Kus E, Chmura-Skirlinska A, Gurbiel R, Wietrzyk J, Chlopicki S. Alterations in NO- and PGI2-dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation. BMC Cancer. 2018;18(1):582.","journal-title":"BMC Cancer"},{"key":"1075_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cpbi.11","volume":"55","author":"J Xia","year":"2016","unstructured":"Xia J, Wishart DS. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics. 2016;55:14 10.1\u201314.10.91.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"1","key":"1075_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","volume":"82","author":"DP SA","year":"2007","unstructured":"SA DP, Hunter KW Jr. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: Association with tumor-derived growth factors. Exp Mol Pathol. 2007;82(1):12\u201324.","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"1075_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2613.2007.00539.x","volume":"88","author":"SA DuPr\u00e9","year":"2007","unstructured":"DuPr\u00e9 SA, Redelman D, Hunter KW. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int J Exp Pathol. 2007;88(5):351\u201360.","journal-title":"Int J Exp Pathol"},{"issue":"6","key":"1075_CR36","doi-asserted-by":"publisher","first-page":"e1316437","DOI":"10.1080\/2162402X.2017.1316437","volume":"6","author":"C Secondini","year":"2017","unstructured":"Secondini C, Coquoz O, Spagnuolo L, Spinetti T, Peyvandi S, Ciarloni L, Botta F, Bourquin C, R\u00fcegg C. Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade. Oncoimmunology. 2017;6(6):e1316437.","journal-title":"Oncoimmunology"},{"issue":"9","key":"1075_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11306-016-1093-7","volume":"12","author":"EG Armitage","year":"2016","unstructured":"Armitage EG, Southam AD. Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics. Metabolomics. 2016;12(9):146.","journal-title":"Metabolomics"},{"issue":"7\u20138","key":"1075_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.intimp.2009.03.021","volume":"9","author":"MK Donkor","year":"2009","unstructured":"Donkor MK, Lahue E, Hoke TA, Shafer LR, Coskun U, Solheim JC, Gulen D, Bishay J, Talmadge JE. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int Immunopharmacol. 2009;9(7\u20138):937\u201348.","journal-title":"Int Immunopharmacol"},{"issue":"1\u20133","key":"1075_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12026-013-8455-2","volume":"57","author":"P Serafini","year":"2013","unstructured":"Serafini P. Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly. Immunol Res. 2013;57(1\u20133):172\u201384.","journal-title":"Immunol Res"},{"issue":"2","key":"1075_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2567.2006.02430.x","volume":"119","author":"R Kim","year":"2006","unstructured":"Kim R, Emi M, Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology. 2006;119(2):254\u201364.","journal-title":"Immunology"},{"issue":"2","key":"1075_CR41","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.18632\/oncotarget.12278","volume":"8","author":"CR Millrud","year":"2017","unstructured":"Millrud CR, Bergenfelz C, Leandersson K. On the origin of myeloid-derived suppressor cells. Oncotarget. 2017;8(2):3649\u201365.","journal-title":"Oncotarget"},{"issue":"11","key":"1075_CR42","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1073\/pnas.1320753111","volume":"111","author":"WC Wu","year":"2014","unstructured":"Wu WC, Sun HW, Chen HT, Liang J, Yu XJ, Wu C, Wang Z, Zheng L. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc Natl Acad Sci U S A. 2014;111(11):4221\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1075_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrc1454","volume":"4","author":"EW Gerner","year":"2004","unstructured":"Gerner EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004;4(10):781\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"1\u20132","key":"1075_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0014-5793(02)03682-7","volume":"532","author":"LE Davel","year":"2002","unstructured":"Davel LE, Jasnis MA, De la Torre E, Gotoh T, Diament M, Magenta G, Sacerdote de Lustig E, Sales ME. Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages. FEBS Lett. 2002;532(1\u20132):216\u201320.","journal-title":"FEBS Lett"},{"issue":"6","key":"1075_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"5","key":"1075_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2008.10.012","volume":"14","author":"H Peinado","year":"2008","unstructured":"Peinado H, Rafii S, Lyden D. Inflammation joins the \u201cniche.\u201d. Cancer Cell. 2008;14(5):347\u20139.","journal-title":"Cancer Cell"},{"key":"1075_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2867-9-9","volume":"9","author":"SM Tsui","year":"2009","unstructured":"Tsui SM, Lam WM, Lam TL, Chong HC, So PK, Kwok SY, Arnold S, Cheng PNM, Wheatley DN, Lo WH, Leung YC. Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC). Cancer Cell Int. 2009;9:9.","journal-title":"Cancer Cell Int"},{"issue":"11","key":"1075_CR48","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nrc.2016.85","volume":"16","author":"LB Sullivan","year":"2016","unstructured":"Sullivan LB, Gui DY, Vander Heiden MG. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat Rev Cancer. 2016;16(11):680\u201393.","journal-title":"Nat Rev Cancer"},{"key":"1075_CR49","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fimmu.2017.00837","volume":"8","author":"CY Tang","year":"2017","unstructured":"Tang CY, Mauro C. Similarities in the metabolic reprogramming of immune system and endothelium. Front Immunol. 2017;8:837.","journal-title":"Front Immunol"},{"key":"1075_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2016.10.008","volume":"52","author":"S Zalba","year":"2017","unstructured":"Zalba S, ten Hagen TLM. Cell membrane modulation as adjuvant in cancer therapy. Cancer Treat Rev. 2017;52:48\u201357.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"1075_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","volume":"9","author":"JM Dean","year":"2017","unstructured":"Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell. 2017;9(2):196\u2013206.","journal-title":"Protein Cell"},{"issue":"11","key":"1075_CR52","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nrc3379","volume":"12","author":"JB Park","year":"2012","unstructured":"Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH. Phospholipase signalling networks in cancer. Nat Rev Cancer. 2012;12(11):782\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1075_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2009.03.027","volume":"15","author":"S Liu","year":"2009","unstructured":"Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, et al. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009;15(6):539\u201350.","journal-title":"Cancer Cell"},{"issue":"5","key":"1075_CR54","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0002-9440(10)64808-0","volume":"157","author":"B Bussolati","year":"2000","unstructured":"Bussolati B, Biancone L, Cassoni P, Russo S, Rola-Pleszczynski M, Montrucchio G, Camussi G. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol. 2000;157(5):1713\u201325.","journal-title":"Am J Pathol"},{"issue":"12","key":"1075_CR55","doi-asserted-by":"publisher","first-page":"e83508","DOI":"10.1371\/journal.pone.0083508","volume":"8","author":"MS Hossain","year":"2013","unstructured":"Hossain MS, Ifuku M, Take S, Kawamura J, Miake K, Katafuchi T. Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling. PLoS One. 2013;8(12):e83508.","journal-title":"PLoS One"},{"issue":"3","key":"1075_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, DuBois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1075_CR57","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2217\/fon.10.116","volume":"6","author":"S Ponnusamy","year":"2010","unstructured":"Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, Salas A, Ogretmen B. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol. 2010;6(10):1603\u201324.","journal-title":"Future Oncol"},{"issue":"6","key":"1075_CR58","doi-asserted-by":"publisher","first-page":"714","DOI":"10.15252\/emmm.201404571","volume":"7","author":"A Carpinteiro","year":"2015","unstructured":"Carpinteiro A, Becker KA, Japtok L, Hessler G, Keitsch S, Po\u017egajov\u00e0 M, Schmid KW, Adams C, M\u00fcller S, Kleuser B, Edwards MJ, Grassm\u00e9 H, Helfrich I, et al. Regulation of hematogenous tumor metastasis by acid sphingomyelinase. EMBO Mol Med. 2015;7(6):714\u201334.","journal-title":"EMBO Mol Med"},{"key":"1075_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jbior.2017.09.006","volume":"68","author":"NJ Pyne","year":"2018","unstructured":"Pyne NJ, El Buri A, Adams DR, Pyne S. Sphingosine 1-phosphate and cancer. Adv Biol Regul. 2018;68:97\u2013106.","journal-title":"Adv Biol Regul"},{"issue":"1","key":"1075_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mvr.2008.09.005","volume":"77","author":"L Wang","year":"2009","unstructured":"Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res. 2009;77(1):39\u201345.","journal-title":"Microvasc Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-1075-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T17:48:05Z","timestamp":1605548885000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-1075-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-1075-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"26 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures involving animals were conducted according to the Guidelines for Animal Care and Treatment of the European Communities and the Guide for the Care and Use of Laboratory Animals issued by the National Institutes of Health. All procedures were approved by the Local Ethical Committee on Animal Experiments at the Jagiellonian University (17\/2016).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"148"}}